200 related articles for article (PubMed ID: 12215251)
1. Characterization of common BRCA1 and BRCA2 variants.
Deffenbaugh AM; Frank TS; Hoffman M; Cannon-Albright L; Neuhausen SL
Genet Test; 2002; 6(2):119-21. PubMed ID: 12215251
[TBL] [Abstract][Full Text] [Related]
2.
Shimelis H; Mesman RLS; Von Nicolai C; Ehlen A; Guidugli L; Martin C; Calléja FMGR; Meeks H; Hallberg E; Hinton J; Lilyquist J; Hu C; Aalfs CM; Aittomäki K; Andrulis I; Anton-Culver H; Arndt V; Beckmann MW; Benitez J; Bogdanova NV; Bojesen SE; Bolla MK; Borresen-Dale AL; Brauch H; Brennan P; Brenner H; Broeks A; Brouwers B; Brüning T; Burwinkel B; Chang-Claude J; Chenevix-Trench G; Cheng CY; Choi JY; Collée JM; Cox A; Cross SS; Czene K; Darabi H; Dennis J; Dörk T; Dos-Santos-Silva I; Dunning AM; Fasching PA; Figueroa J; Flyger H; García-Closas M; Giles GG; Glendon G; Guénel P; Haiman CA; Hall P; Hamann U; Hartman M; Hogervorst FB; Hollestelle A; Hopper JL; Ito H; Jakubowska A; Kang D; Kosma VM; Kristensen V; Lai KN; Lambrechts D; Marchand LL; Li J; Lindblom A; Lophatananon A; Lubinski J; Machackova E; Mannermaa A; Margolin S; Marme F; Matsuo K; Miao H; Michailidou K; Milne RL; Muir K; Neuhausen SL; Nevanlinna H; Olson JE; Olswold C; Oosterwijk JJC; Osorio A; Peterlongo P; Peto J; Pharoah PDP; Pylkäs K; Radice P; Rashid MU; Rhenius V; Rudolph A; Sangrajrang S; Sawyer EJ; Schmidt MK; Schoemaker MJ; Seynaeve C; Shah M; Shen CY; Shrubsole M; Shu XO; Slager S; Southey MC; Stram DO; Swerdlow A; Teo SH; Tomlinson I; Torres D; Truong T; van Asperen CJ; van der Kolk LE; Wang Q; Winqvist R; Wu AH; Yu JC; Zheng W; Zheng Y; Leary J; Walker L; Foretova L; Fostira F; Claes KBM; Varesco L; Moghadasi S; Easton DF; Spurdle A; Devilee P; Vrieling H; Monteiro ANA; Goldgar DE; Carreira A; Vreeswijk MPG; Couch FJ; ;
Cancer Res; 2017 Jun; 77(11):2789-2799. PubMed ID: 28283652
[TBL] [Abstract][Full Text] [Related]
3. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
Parsons MT; Tudini E; Li H; Hahnen E; Wappenschmidt B; Feliubadaló L; Aalfs CM; Agata S; Aittomäki K; Alducci E; Alonso-Cerezo MC; Arnold N; Auber B; Austin R; Azzollini J; Balmaña J; Barbieri E; Bartram CR; Blanco A; Blümcke B; Bonache S; Bonanni B; Borg Å; Bortesi B; Brunet J; Bruzzone C; Bucksch K; Cagnoli G; Caldés T; Caliebe A; Caligo MA; Calvello M; Capone GL; Caputo SM; Carnevali I; Carrasco E; Caux-Moncoutier V; Cavalli P; Cini G; Clarke EM; Concolino P; Cops EJ; Cortesi L; Couch FJ; Darder E; de la Hoya M; Dean M; Debatin I; Del Valle J; Delnatte C; Derive N; Diez O; Ditsch N; Domchek SM; Dutrannoy V; Eccles DM; Ehrencrona H; Enders U; Evans DG; Farra C; Faust U; Felbor U; Feroce I; Fine M; Foulkes WD; Galvao HCR; Gambino G; Gehrig A; Gensini F; Gerdes AM; Germani A; Giesecke J; Gismondi V; Gómez C; Gómez Garcia EB; González S; Grau E; Grill S; Gross E; Guerrieri-Gonzaga A; Guillaud-Bataille M; Gutiérrez-Enríquez S; Haaf T; Hackmann K; Hansen TVO; Harris M; Hauke J; Heinrich T; Hellebrand H; Herold KN; Honisch E; Horvath J; Houdayer C; Hübbel V; Iglesias S; Izquierdo A; James PA; Janssen LAM; Jeschke U; Kaulfuß S; Keupp K; Kiechle M; Kölbl A; Krieger S; Kruse TA; Kvist A; Lalloo F; Larsen M; Lattimore VL; Lautrup C; Ledig S; Leinert E; Lewis AL; Lim J; Loeffler M; López-Fernández A; Lucci-Cordisco E; Maass N; Manoukian S; Marabelli M; Matricardi L; Meindl A; Michelli RD; Moghadasi S; Moles-Fernández A; Montagna M; Montalban G; Monteiro AN; Montes E; Mori L; Moserle L; Müller CR; Mundhenke C; Naldi N; Nathanson KL; Navarro M; Nevanlinna H; Nichols CB; Niederacher D; Nielsen HR; Ong KR; Pachter N; Palmero EI; Papi L; Pedersen IS; Peissel B; Perez-Segura P; Pfeifer K; Pineda M; Pohl-Rescigno E; Poplawski NK; Porfirio B; Quante AS; Ramser J; Reis RM; Revillion F; Rhiem K; Riboli B; Ritter J; Rivera D; Rofes P; Rump A; Salinas M; Sánchez de Abajo AM; Schmidt G; Schoenwiese U; Seggewiß J; Solanes A; Steinemann D; Stiller M; Stoppa-Lyonnet D; Sullivan KJ; Susman R; Sutter C; Tavtigian SV; Teo SH; Teulé A; Thomassen M; Tibiletti MG; Tischkowitz M; Tognazzo S; Toland AE; Tornero E; Törngren T; Torres-Esquius S; Toss A; Trainer AH; Tucker KM; van Asperen CJ; van Mackelenbergh MT; Varesco L; Vargas-Parra G; Varon R; Vega A; Velasco Á; Vesper AS; Viel A; Vreeswijk MPG; Wagner SA; Waha A; Walker LC; Walters RJ; Wang-Gohrke S; Weber BHF; Weichert W; Wieland K; Wiesmüller L; Witzel I; Wöckel A; Woodward ER; Zachariae S; Zampiga V; Zeder-Göß C; ; Lázaro C; De Nicolo A; Radice P; Engel C; Schmutzler RK; Goldgar DE; Spurdle AB
Hum Mutat; 2019 Sep; 40(9):1557-1578. PubMed ID: 31131967
[TBL] [Abstract][Full Text] [Related]
4.
Khan MA; Varma AK
J Biomol Struct Dyn; 2023 Nov; 41(19):9879-9889. PubMed ID: 36404616
[TBL] [Abstract][Full Text] [Related]
5. Towards a New, Endophenotype-Based Strategy for Pathogenicity Prediction in BRCA1 and BRCA2: In Silico Modeling of the Outcome of HDR/SGE Assays for Missense Variants.
Özkan S; Padilla N; de la Cruz X
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207612
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 Circos: a visualisation resource for functional analysis of missense variants.
Jhuraney A; Velkova A; Johnson RC; Kessing B; Carvalho RS; Whiley P; Spurdle AB; Vreeswijk MP; Caputo SM; Millot GA; Vega A; Coquelle N; Galli A; Eccles D; Blok MJ; Pal T; van der Luijt RB; Santamariña Pena M; Neuhausen SL; Donenberg T; Machackova E; Thomas S; Vallée M; Couch FJ; Tavtigian SV; Glover JN; Carvalho MA; Brody LC; Sharan SK; Monteiro AN;
J Med Genet; 2015 Apr; 52(4):224-30. PubMed ID: 25643705
[TBL] [Abstract][Full Text] [Related]
7. Characterization of BRCA2 R3052Q variant in mice supports its functional impact as a low-risk variant.
Mishra AP; Hartford S; Chittela RK; Sahu S; Kharat SS; Alvaro-Aranda L; Contreras-Perez A; Sullivan T; Martin BK; Albaugh M; Southon E; Burkett S; Karim B; Carreira A; Tessarollo L; Sharan SK
Cell Death Dis; 2023 Nov; 14(11):753. PubMed ID: 37980415
[TBL] [Abstract][Full Text] [Related]
8. Toward classification of BRCA1 missense variants using a biophysical approach.
Rowling PJ; Cook R; Itzhaki LS
J Biol Chem; 2010 Jun; 285(26):20080-7. PubMed ID: 20378548
[TBL] [Abstract][Full Text] [Related]
9. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.
Li H; Engel C; Hoya M; Peterlongo P; Yannoukakos D; Livraghi L; Radice P; Thomassen M; Hansen TVO; Gerdes AM; Nielsen HR; Caputo SM; Zambelli A; Borg A; Solano A; Thomas A; Parsons MT; Antoniou AC; Leslie G; Yang X; Chenevix-Trench G; Caldes T; Kwong A; Pedersen IS; Lautrup CK; John EM; Terry MB; Hopper JL; Southey MC; Andrulis IL; Tischkowitz M; Janavicius R; Boonen SE; Kroeldrup L; Varesco L; Hamann U; Vega A; Palmero EI; Garber J; Montagna M; Van Asperen CJ; Foretova L; Greene MH; Selkirk T; Moller P; Toland AE; Domchek SM; James PA; Thorne H; Eccles DM; Nielsen SM; Manoukian S; Pasini B; Caligo MA; Lazaro C; Kirk J; Wappenschmidt B; Spurdle AB; Couch FJ; Schmutzler R; Goldgar DE;
Genet Med; 2022 Oct; 24(10):2208. PubMed ID: 36205748
[No Abstract] [Full Text] [Related]
10. Correction: The frequency and pathogenicity of BRCA1 and BRCA2 variants in the general Japanese population.
Idogawa M; Mariya T; Tanaka Y; Saito T; Nakase H; Tokino T; Sakurai A
J Hum Genet; 2024 May; 69(5):231-234. PubMed ID: 38480854
[No Abstract] [Full Text] [Related]
11. Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.
Bodian DL; McCutcheon JN; Kothiyal P; Huddleston KC; Iyer RK; Vockley JG; Niederhuber JE
PLoS One; 2014; 9(4):e94554. PubMed ID: 24728327
[TBL] [Abstract][Full Text] [Related]
12. A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).
Lindor NM; Guidugli L; Wang X; Vallée MP; Monteiro AN; Tavtigian S; Goldgar DE; Couch FJ
Hum Mutat; 2012 Jan; 33(1):8-21. PubMed ID: 21990134
[TBL] [Abstract][Full Text] [Related]
13. Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes.
Johnston JJ; Rubinstein WS; Facio FM; Ng D; Singh LN; Teer JK; Mullikin JC; Biesecker LG
Am J Hum Genet; 2012 Jul; 91(1):97-108. PubMed ID: 22703879
[TBL] [Abstract][Full Text] [Related]
14. Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling.
Capanu M; Concannon P; Haile RW; Bernstein L; Malone KE; Lynch CF; Liang X; Teraoka SN; Diep AT; Thomas DC; Bernstein JL; ; Begg CB
Genet Epidemiol; 2011 Jul; 35(5):389-97. PubMed ID: 21520273
[TBL] [Abstract][Full Text] [Related]
15. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.
Easton DF; Deffenbaugh AM; Pruss D; Frye C; Wenstrup RJ; Allen-Brady K; Tavtigian SV; Monteiro AN; Iversen ES; Couch FJ; Goldgar DE
Am J Hum Genet; 2007 Nov; 81(5):873-83. PubMed ID: 17924331
[TBL] [Abstract][Full Text] [Related]
16. Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations.
Wagner TM; Hirtenlehner K; Shen P; Moeslinger R; Muhr D; Fleischmann E; Concin H; Doeller W; Haid A; Lang AH; Mayer P; Petru E; Ropp E; Langbauer G; Kubista E; Scheiner O; Underhill P; Mountain J; Stierer M; Zielinski C; Oefner P
Hum Mol Genet; 1999 Mar; 8(3):413-23. PubMed ID: 9971877
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral.
Tavtigian SV; Deffenbaugh AM; Yin L; Judkins T; Scholl T; Samollow PB; de Silva D; Zharkikh A; Thomas A
J Med Genet; 2006 Apr; 43(4):295-305. PubMed ID: 16014699
[TBL] [Abstract][Full Text] [Related]
18. Classifying Variants of Undetermined Significance in BRCA2 with protein likelihood ratios.
Karchin R; Agarwal M; Sali A; Couch F; Beattie MS
Cancer Inform; 2008; 6():203-16. PubMed ID: 19043619
[TBL] [Abstract][Full Text] [Related]
19. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M
Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
